Press Releases
AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan
AstraZeneca’s COVID-19 vaccine, Vaxzevria (ChAdOx1-S ), formerly AZD1222, has been granted a special approval for emergency use in Japan for active immunisation of individuals...
Clinical Trials
Moderna Reports Positive COVID-19 Vaccine Results in Adolescents
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Phase 2/3 study of its COVID-19 vaccine (mRNA-1273) in...
News
CanSino Biologics Gets OGYEI GMP Certificate for COVID Vax
CanSino Biologics Recombinant Novel Coronavirus Vaccine, (Adenovirus Type 5 Vector, trade name Convidecia), has been granted a Good Manufacturing Practice certificate by the Hungarian...
Packaging & Labelling
UPS Healthcare Accelerates Cold Chain Capabilities
UPS is expanding its specialty pharmaceutical offerings by establishing UPS Cold Chain Solutions, a comprehensive suite of cold chain technologies, best-in-class capabilities, and new...
News
ANVISA Sorrento Phase 2 Pivotal Clinical Trial of COVI-MSC in Hospitalized COVID-19 Patients With Acute Respiratory Distress Syndrome
Sorrento Therapeutics, Inc. announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed with a Phase 2 Pivotal clinical trial of COVI-MSC™,...
White Papers
The Future of Tech in Nutraceuticals Industry
Nutrify Today, India’s first and only nutraceuticals i2C (ideas to commercialization) platform has been engaging and empowering the responsible nutrition industry through knowledge, connections,...
Industry Reports
Artificial Intelligence to play a role in Nutraceuticals industry, India to be a leading player: Nutrify Today survey
A global industry survey conducted by Nutrify, the world’s first and only nutraceuticals i2c (ideas to commercialization) platform, has found that there is growing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read